Novartis and IBM Watson are working together on a new initiative to improve cancer care. In what the pharmaceutical company called a “first-of-its-kind collaboration, the two will use IBM Watson’s cognitive computing tools to leverage Novartis’s portfolio of breast cancer compounds and real-world patient data. The goal is to use data analytics and machine learning to determine which combinations...
